Supernus Pharmaceuticals Inc (SUPN)
35.81
-0.31
(-0.86%)
USD |
NASDAQ |
Nov 21, 16:00
35.81
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Price to Book Value: 1.963 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.980 |
| November 19, 2024 | 1.948 |
| November 18, 2024 | 1.933 |
| November 15, 2024 | 1.950 |
| November 14, 2024 | 1.984 |
| November 13, 2024 | 2.071 |
| November 12, 2024 | 2.074 |
| November 11, 2024 | 2.007 |
| November 08, 2024 | 2.007 |
| November 07, 2024 | 1.996 |
| November 06, 2024 | 2.070 |
| November 05, 2024 | 1.905 |
| November 04, 2024 | 1.902 |
| November 01, 2024 | 1.862 |
| October 31, 2024 | 1.868 |
| October 30, 2024 | 1.912 |
| October 29, 2024 | 1.885 |
| October 28, 2024 | 1.873 |
| October 25, 2024 | 1.860 |
| October 24, 2024 | 1.853 |
| October 23, 2024 | 1.857 |
| October 22, 2024 | 1.848 |
| October 21, 2024 | 1.846 |
| October 18, 2024 | 1.894 |
| October 17, 2024 | 1.855 |
| Date | Value |
|---|---|
| October 16, 2024 | 1.863 |
| October 15, 2024 | 1.838 |
| October 14, 2024 | 1.805 |
| October 11, 2024 | 1.809 |
| October 10, 2024 | 1.748 |
| October 09, 2024 | 1.775 |
| October 08, 2024 | 1.782 |
| October 07, 2024 | 1.758 |
| October 04, 2024 | 1.756 |
| October 03, 2024 | 1.76 |
| October 02, 2024 | 1.763 |
| October 01, 2024 | 1.754 |
| September 30, 2024 | 1.710 |
| September 27, 2024 | 1.770 |
| September 26, 2024 | 1.771 |
| September 25, 2024 | 1.723 |
| September 24, 2024 | 1.759 |
| September 23, 2024 | 1.808 |
| September 20, 2024 | 1.831 |
| September 19, 2024 | 1.849 |
| September 18, 2024 | 1.832 |
| September 17, 2024 | 1.826 |
| September 16, 2024 | 1.812 |
| September 13, 2024 | 1.790 |
| September 12, 2024 | 1.778 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.275
Minimum
Mar 18 2020
2.573
Maximum
Feb 02 2023
1.915
Average
1.905
Median
Price to Book Value Benchmarks
| Regeneron Pharmaceuticals Inc | 2.790 |
| United Therapeutics Corp | 2.685 |
| Ligand Pharmaceuticals Inc | 2.626 |
| Tonix Pharmaceuticals Holding Corp | 0.5075 |
| Agios Pharmaceuticals Inc | 1.948 |
Price to Book Value Related Metrics
| PE Ratio | 33.48 |
| PS Ratio | 3.058 |
| PEG Ratio | 0.2081 |
| Price to Free Cash Flow | 11.59 |
| Price | 35.81 |
| Earnings Yield | 2.99% |
| Market Cap | 1.977B |
| PEGY Ratio | 0.2081 |
| Operating PE Ratio | 27.39 |
| Normalized PE Ratio | 28.31 |